For clinicians: why perimenopause so often unmasks ADHD in women—the hormonal mechanism, why it was missed for decades, and what recognition asks of us.

​

​

​

​

​

​

​

​

​

​

​

​

​

​

The hormonal exacerbation of ADHD is not a perimenopause story and not an estrogen-only one. Two hormones modulate two systems — estrogen the dopaminergic, progesterone the GABAergic — at every reproductive hinge point. Holding both across the arc changes how we read a midlife presentation. Here is the frame, the evidence, and where it points.

​

​Rejection sensitive dysphoria has moved from clinical anecdote to client vocabulary faster than the research can keep pace. For those of us working where ADHD, trauma, and hormonal transition overlap, the concept is clinically useful and worth holding carefully. Here is what the evidence supports, what it does not, and why the late-diagnosed midlife woman is where this most often lands.

When a client's symptom picture shifts predictably — across the month, or across the transition into perimenopause — the fluctuation itself is assessment data. One estrogen-linked mechanism operates on two timescales, and it is often what finally surfaces a long-missed diagnosis. Here is what the peer-reviewed evidence supports and how I hold it clinically.

The question "ADHD or trauma?" is the wrong spine for assessment in women with layered histories — especially the many who arrive late, when perimenopause has stripped away decades of compensation. A lifespan-informed formulation asks something more useful. Here is the orienting frame I use and the six domains that carry it.​​​

more to come